Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)

Part of paid clinical trials in Nashville, Tennessee.

Sponsor
Vanderbilt University Medical Center
Study ID
NCT07612644
Status
Recruiting

Conditions

  • Lumbar Puncture

Eligibility Criteria

Sex
ALL
Age
1 Day - 12 Months
Healthy Volunteers
Not accepted

Interventions

  • ultrasound contrast — DEVICE
    Ultrasound of spinal canal without contrast. We included the term "ultrasound contrast" because the choices were limited.

Study Details

This is a clinical trial to determine the extent to which ultrasound-assisted lumbar puncture using a standardized procedure, including use of ultrasound to ascertain the presence of cerebrospinal fluid (CSF) at L3 - L5 and the optimal needle insertion distance, increases the acquisition rate of CSF that is interpretable for patient management.

Key Dates

Start date
May 16, 2026
Status verified
May 2026
Primary completion
Jun 30, 2027
Completion
Jun 30, 2028

Study Design

Enrollment
80 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Ultrasound
    Intervention: Ultrasound of spinal canal
  • No Intervention: Control Group
    Infants undergoing lumbar puncture without ultrasound assist

Primary Outcome Measure

Successful LP rate [ Time Frame: Time from lumbar puncture to results of CSF returned by lab, approximately 1 hour. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Vanderbilt University Medical CenterNashvilleTennessee37232
Donald H Arnold, MD, MPH
615-936-4498

Find similar trials in Nashville, TN